Most patients receive same-day approval
That distinction is exactly what should come first, not the hasty discontinuation of a therapy that makes medical sense
Other important risk factors include: Advanced age (65 years and older), as older adults have decreased thirst perception and reduced baseline kidney function Concurrent use of medications affecting renal hemodynamics or fluid balance , including NSAIDs, ACE inhibitors, ARBs, and diuretics, which may increase AKI risk during dehydration Diabetes with diabetic nephropathy , where baseline kidney function may already be compromised Heart failure , particularly when treated with diuretics, increasing dehydration risk Patients taking multiple medications that affect fluid balance or those with limited fluid intake due to mobility issues face elevated risk
Standard Dosing Tirzepatide is a dual-action GLP-1 and GIP agonist
Additional information Digital Features To view digital features for this article go to Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
/assets/images/provider/photos/2830212.jpg)
